Skip to content

Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance

Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01408498
Enrollment
120
Registered
2011-08-03
Start date
2012-01-31
Completion date
2012-04-30
Last updated
2012-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testosterone's Effects on Threat Perception/Response

Keywords

Testosterone, Social psychology, Human behavior

Brief summary

The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure, heart rate, and endocrine responses) and a decreased behavioral response (e.g., ignoring the threat, avoiding the threat, and postponing dealing with the threat). The threat in this study is a social threat involving public speaking, and is an outgrowth of previous research on the avoidance of health threats.

Detailed description

Participants in the study will receive either a single dose of 10g 1% testosterone topical gel or placebo the day prior to participating in the study. The day of the study, participants will provide saliva samples throughout the study to track testosterone and cortisol levels. Participants will be asked to complete the Trier Social Stressor Task, which includes having to give a 5 minute speech to a panel of judges. Participants will be given the opportunity to postpone giving their speech to an unspecified date. The study will focus on two types of responses to the threat of public speaking: behavioral and physiological. The behavior of interest will be participants desire to postpone dealing with the threat (it is hypothesized that those in the testosterone administration group will have an increased desire to postpone). The physiological responses include increased levels of cortisol and increased cardiovascular tone (it is hypothesized that the testosterone administration group will show an increased physiological response compared to the placebo group).

Interventions

DRUGTestosterone

Topical administration of testosterone gel. Participants receive a one-time, single dose of 10 g of 1% testosterone gel.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * In good health * Aged 18-35

Exclusion criteria

* Female * Known carcinoma of the breast or prostate * Known sensitivity to alcohol or soy products * Preexisting cardiac, renal, or hepatic diseases * Obesity * Chronic lung diseases * Cancer * Use of anticoagulants * Use of insulin or a history of diabetes * Use of corticosteroids * High levels of physical contact with women or children * Preexisting liver problems

Design outcomes

Primary

MeasureTime frameDescription
Behavioral response16 hours post testosterone administrationParticipants will be asked to give a public speech, but will be given the opportunity to postpone the speech to a future date. Postponement is considered an avoidance-oriented behavioral response to a perceived social threat.
Physiological response16 hours post testosterone administrationParticipants will have cortisol and cardiovascular tone tracked during the social threat protocol. Prior to, during, and after being asked, preparing, and giving a public speech, participants' physiological stress markers will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026